DEERFIELD, Ill., April 26 Takeda Pharmaceuticals North America, Inc. today announced that DEXILANT(TM) (dexlansoprazole) delayed release capsules are now available in United States (U.S.) pharmacies.

DEERFIELD, Ill., Nov. 17, 2011 /PRNewswire/ -- Today, Takeda Pharmaceuticals North America, Inc., (Takeda) announced the DEXILANT (dexlansoprazole) product labeling now includes information from a ...

DEERFIELD, Ill., Jan. 27, 2016 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc., (Takeda) (TSE: 4502) today announced that the United States (U.S.) Food and Drug Administration (FDA) approved ...

Takeda announced that it has updated the product labeling for Dexilant (dexlansoprazole) to include information demonstrating that Dexilant had no clinically important effect on exposure to the active ...

Takeda Pharmaceuticals’ Dexilant SoluTab delayed-release orally disintegrating tablets received FDA approval. 1. The tablets are a new formulation of dexlansoprazole that can be taken by allowing the ...

Takeda announced that the Food and Drug Administration (FDA) has approved Dexilant (dexlansoprazole) delayed-release capsules and Dexilant SoluTab delayed-release orally-disintegrating tablets for ...

Please provide your email address to receive an email when new articles are posted on . Takeda has announced that the FDA approved its Dexilant SoluTab delayed-release formulation of the proton pump ...

HAYWARD, Calif. — Generic drug maker Impax Labs is hoping to become the first to market a version of a gastroesophageal reflux disease treatment made by Takeda Pharmaceutical. Impax said Tuesday that ...

H-E-B joined a lawsuit with Kroger, Albertsons and Walgreens against a pharmaceutical company over conspiring to delay the generic version of a drug. The companies hit Takeda and TWi Pharmaceuticals ...